Home/Filings/4/0001005286-25-000070
4//SEC Filing

Salus Thomas D. 4

Accession 0001005286-25-000070

CIK 0001005286other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 4:38 PM ET

Size

10.7 KB

Accession

0001005286-25-000070

Insider Transaction Report

Form 4
Period: 2025-04-14
Salus Thomas D.
Chief Legal & Administration
Transactions
  • Award

    Performance-Based Restricted Stock Units

    2025-04-14+370,0000 total
    Exp: 2030-04-14Common Stock (370,000 underlying)
  • Award

    Common Stock

    2025-04-14+170,000215,000 total
  • Award

    Incentive Stock Option (Right to Buy)

    2025-04-14+210,000210,000 total
    Exercise: $6.17From: 2026-04-14Exp: 2032-04-14Common Stock (210,000 underlying)
  • Award

    Common Stock

    2025-04-14+45,00045,000 total
Footnotes (4)
  • [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
  • [F2]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.
  • [F4]The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock prices.

Issuer

LIFECORE BIOMEDICAL, INC. \DE\

CIK 0001005286

Entity typeother

Related Parties

1
  • filerCIK 0002062209

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:38 PM ET
Size
10.7 KB